A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

These findings counter clinical trial results published in June which found that Paxlovid was safe to take but did not lessen ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds, and that’s definitely the case right now for Georgia and South Carolina.

An extended course of the antiviral medication Paxlovid may offer relief to individuals suffering from long COVID, suggests a study by UC San Francisco researchers. With around 17.6 million ...

There's no medication for norovirus. Instead, you'll need to rehydrate as much as possible with water and other liquids. Seek help if you are dehydrated and notice you have a dry mouth and throat, ...

An extended course of antiviral medication Paxlovid may benefit some patients with long COVID, suggests a new study. A case series by UC San Francisco researchers hints that the antiviral medication ...